Skin Glue Earns Highest Overall Satisfaction Rating
Dermabond is now routine for abdominal incisions.
Points of Interest : 2005 – Skin Glue Earns Highest Overall Satisfaction Rating
Ethicon Inc., a global medical device company, announced the results of an
international clinical study demonstrating that the company’s DERMABOND Topical Skin
Adhesive is equivalent to sutures and other traditional epidermal wound closure
devices in closing long surgical incisions. The study examined the use of DERMABOND
Adhesive to close incisions varying in length from four to 69 cm, across six
surgical specialties including plastic, general, maxillofacial, neuro, OB/GYN and
thoracic surgery.
Patient inclusion criteria included those over the age of 18 who required primary
closure of at least one full thickness surgical incision in length and who may have
been in need of deep wound sutures to relieve skin tension. Main exclusion criteria
included patients with peripheral vascular disease, insulin-dependent diabetes
mellitus, a blood clotting disorder or receipt of anticolagulants within seven days
of surgery. The study found that those receiving treatment with DERMABOND Adhesive
experienced equivalent wound healing at day 10 in all three effectiveness analyses
as compared to the control group.
Approved by the U.S Food and Drug Administration in 1998, DERMABOND Adhesive has
been used extensively by healthcare professionals in the fields of trauma, plastic
and other surgeries, emergency medicine, and pediatrics. Since its approval,
DERMABOND Adhesive has proven useful in closing surgical incisions where suture
removal can cause significant discomfort. The adhesive does not produce suture or
“track” marks along the healed incision and unlike stitches, a patient can shower
right away without fear of compromising the incision.
DERMABOND Topical Skin Adhesive is licensed by ETHICON from Closure Medical
Corporation, based in Raleigh, North Carolina.